GB1395820A - Preparation of 21-inorganic esters of corticosteroids and salts thereof - Google Patents
Preparation of 21-inorganic esters of corticosteroids and salts thereofInfo
- Publication number
- GB1395820A GB1395820A GB2241272A GB2241272A GB1395820A GB 1395820 A GB1395820 A GB 1395820A GB 2241272 A GB2241272 A GB 2241272A GB 2241272 A GB2241272 A GB 2241272A GB 1395820 A GB1395820 A GB 1395820A
- Authority
- GB
- United Kingdom
- Prior art keywords
- sodium
- salts
- potassium
- dbed
- dibenzylethylenediamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000003839 salts Chemical class 0.000 title abstract 3
- 239000003246 corticosteroid Substances 0.000 title abstract 2
- 229960001334 corticosteroids Drugs 0.000 title 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 abstract 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 2
- JUHORIMYRDESRB-UHFFFAOYSA-N benzathine Chemical compound C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 abstract 2
- 229960002537 betamethasone Drugs 0.000 abstract 2
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 abstract 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 abstract 2
- 239000011591 potassium Substances 0.000 abstract 2
- 229910052700 potassium Inorganic materials 0.000 abstract 2
- 239000011734 sodium Substances 0.000 abstract 2
- 229910052708 sodium Inorganic materials 0.000 abstract 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 abstract 2
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 abstract 1
- VHRSUDSXCMQTMA-PJHHCJLFSA-N 6alpha-methylprednisolone Chemical compound C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)CO)CC[C@H]21 VHRSUDSXCMQTMA-PJHHCJLFSA-N 0.000 abstract 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 abstract 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 abstract 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 abstract 1
- MKPDWECBUAZOHP-AFYJWTTESA-N Paramethasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]2(C)C[C@@H]1O MKPDWECBUAZOHP-AFYJWTTESA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- -1 amine salts Chemical class 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 229960004544 cortisone Drugs 0.000 abstract 1
- 229960003957 dexamethasone Drugs 0.000 abstract 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 abstract 1
- 229940043075 fluocinolone Drugs 0.000 abstract 1
- FEBLZLNTKCEFIT-VSXGLTOVSA-N fluocinolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O FEBLZLNTKCEFIT-VSXGLTOVSA-N 0.000 abstract 1
- 229960000890 hydrocortisone Drugs 0.000 abstract 1
- 239000012442 inert solvent Substances 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 235000010755 mineral Nutrition 0.000 abstract 1
- 229960002858 paramethasone Drugs 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 235000015497 potassium bicarbonate Nutrition 0.000 abstract 1
- 229960005205 prednisolone Drugs 0.000 abstract 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 abstract 1
- 229960004618 prednisone Drugs 0.000 abstract 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 abstract 1
- 239000011541 reaction mixture Substances 0.000 abstract 1
- 238000010992 reflux Methods 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
- 150000003512 tertiary amines Chemical class 0.000 abstract 1
- 229960005294 triamcinolone Drugs 0.000 abstract 1
- GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT5588771 | 1971-06-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1395820A true GB1395820A (en) | 1975-05-29 |
Family
ID=20081745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB2241272A Expired GB1395820A (en) | 1971-06-05 | 1972-05-12 | Preparation of 21-inorganic esters of corticosteroids and salts thereof |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US3773803A (cg-RX-API-DMAC7.html) |
| JP (1) | JPS546553B1 (cg-RX-API-DMAC7.html) |
| AR (1) | AR193093A1 (cg-RX-API-DMAC7.html) |
| AT (1) | AT347052B (cg-RX-API-DMAC7.html) |
| BE (1) | BE784409A (cg-RX-API-DMAC7.html) |
| CA (1) | CA983019A (cg-RX-API-DMAC7.html) |
| CH (1) | CH578015A5 (cg-RX-API-DMAC7.html) |
| DK (1) | DK135379B (cg-RX-API-DMAC7.html) |
| ES (1) | ES403399A1 (cg-RX-API-DMAC7.html) |
| FR (1) | FR2143690B1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB1395820A (cg-RX-API-DMAC7.html) |
| HK (1) | HK78979A (cg-RX-API-DMAC7.html) |
| NL (1) | NL7207617A (cg-RX-API-DMAC7.html) |
| NO (1) | NO138092C (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA723373B (cg-RX-API-DMAC7.html) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007039635A3 (en) * | 2005-10-06 | 2007-06-21 | Innate Pharma Sa | Phosphoantigen salts of organic bases and methods for their crystallization |
| CN114685595A (zh) * | 2020-12-30 | 2022-07-01 | 天津药业研究院股份有限公司 | 倍他米松磷酸酯二水合物及其制备方法和应用 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4904768A (en) * | 1987-08-04 | 1990-02-27 | Bristol-Myers Company | Epipodophyllotoxin glucoside 4'-phosphate derivatives |
-
1972
- 1972-05-12 GB GB2241272A patent/GB1395820A/en not_active Expired
- 1972-05-15 DK DK240872AA patent/DK135379B/da unknown
- 1972-05-17 ZA ZA723373A patent/ZA723373B/xx unknown
- 1972-05-17 CA CA142,424A patent/CA983019A/en not_active Expired
- 1972-05-26 US US00257321A patent/US3773803A/en not_active Expired - Lifetime
- 1972-05-26 JP JP5240672A patent/JPS546553B1/ja active Pending
- 1972-05-30 NO NO1911/72A patent/NO138092C/no unknown
- 1972-05-30 AR AR242255A patent/AR193093A1/es active
- 1972-05-31 ES ES403399A patent/ES403399A1/es not_active Expired
- 1972-05-31 AT AT471872A patent/AT347052B/de not_active IP Right Cessation
- 1972-06-02 CH CH821472A patent/CH578015A5/xx not_active IP Right Cessation
- 1972-06-05 NL NL7207617A patent/NL7207617A/xx unknown
- 1972-06-05 FR FR7220152A patent/FR2143690B1/fr not_active Expired
- 1972-06-05 BE BE784409A patent/BE784409A/xx unknown
-
1979
- 1979-11-15 HK HK789/79A patent/HK78979A/xx unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007039635A3 (en) * | 2005-10-06 | 2007-06-21 | Innate Pharma Sa | Phosphoantigen salts of organic bases and methods for their crystallization |
| CN114685595A (zh) * | 2020-12-30 | 2022-07-01 | 天津药业研究院股份有限公司 | 倍他米松磷酸酯二水合物及其制备方法和应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| NL7207617A (cg-RX-API-DMAC7.html) | 1972-12-07 |
| AU4258572A (en) | 1973-11-29 |
| NO138092C (no) | 1978-06-28 |
| HK78979A (en) | 1979-11-23 |
| AR193093A1 (es) | 1973-03-30 |
| BE784409A (fr) | 1972-12-05 |
| DK135379C (cg-RX-API-DMAC7.html) | 1977-10-03 |
| NO138092B (no) | 1978-03-20 |
| DE2225658B2 (de) | 1976-04-08 |
| FR2143690B1 (cg-RX-API-DMAC7.html) | 1976-03-05 |
| ES403399A1 (es) | 1975-04-16 |
| CA983019A (en) | 1976-02-03 |
| JPS546553B1 (cg-RX-API-DMAC7.html) | 1979-03-29 |
| AT347052B (de) | 1978-12-11 |
| US3773803A (en) | 1973-11-20 |
| FR2143690A1 (cg-RX-API-DMAC7.html) | 1973-02-09 |
| CH578015A5 (cg-RX-API-DMAC7.html) | 1976-07-30 |
| DK135379B (da) | 1977-04-18 |
| DE2225658A1 (de) | 1972-12-14 |
| ATA471872A (de) | 1978-04-15 |
| ZA723373B (en) | 1973-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1494097A (en) | D-homo-20-keto-pregnanes | |
| WO1991001991A1 (en) | New topically active steroidal anti-inflammatory agents | |
| US2865935A (en) | 2-methyl steroids and process | |
| GB1328998A (en) | Process of corticosteroids | |
| US3206359A (en) | Galacturonides of the anti-inflammatory pregnane series | |
| US3882151A (en) | Chemical compounds | |
| US3055922A (en) | 16-methyl-17alpha-hydroxy-3, 20-diketopregnanes | |
| US3043833A (en) | 17-cyanohydrin of 19-nor androstenedione and 3-derivatives thereof | |
| US3766223A (en) | Disteroidyl ethers | |
| US3282929A (en) | Method for preparation of aromatic a ring steroids | |
| SE7513200L (sv) | Steroid(16alfa,17-b)naftalener | |
| US3242169A (en) | 6alpha-dimethylaminomethyl-3-oxo-delta4-steroids and method for producing same | |
| GB1306622A (en) | Process for the preparation of 21-deoxy-21-4-methyl-1-piperazinyl- prednisolone and salts | |
| GB1514621A (en) | 13-ethynyl-and 13-(2-halovinyl)-steroids and their preparation | |
| US3773803A (en) | Process of preparation of 21-sulfate and 21-phosphate esters of corticosteroids | |
| US3798217A (en) | Novel c-16,17 spiro-orthoester steroids and preparation | |
| US3236866A (en) | 21, 21-difluoro pregnenes | |
| GB1511820A (en) | 16-methyl-9alpha-halo steroid ethers and esters and their preparation | |
| US3580935A (en) | Process for the preparation of 3-enol ethers of 3-keto-delta**4 - 6-(n-disubstituted) aminomethyl steroids | |
| GB836654A (en) | Water-soluble phosphorus derivatives of saturated or unsaturated compounds of the pregnene series | |
| GB1223087A (en) | Improvements in or relating to new steroid 21-esters, method for their preparation and therapeutic composition containing same | |
| GB1317185A (en) | Acyloxy-3alpha-hydroxy-pregnones | |
| US2739162A (en) | Hydrogenation of chloropregnenes | |
| AT275055B (de) | Verfahren zur Herstellung von neuen 4-Methyl-9β,10α-Steroiden | |
| DE1214677B (de) | Verfahren zur Herstellung von 17alpha-Acyloxy-21-hydroxysteroiden |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PE20 | Patent expired after termination of 20 years |